How a Global Pharmaceutical Company Made Complex Science Worth Listening To

A global pharmaceutical company wanted to create more meaningful conversations around the research, scientists and persistence behind medical progress. The company works on some of medicine's hardest problems. Its researchers spend years studying disease, developing new therapies and trying to solve questions that rarely have simple answers. That expertise created a communications challenge. Pharmaceutical research is complex. The language can be technical. The science needs to be precise. And anything published by a pharmaceutical company has to move through a demanding medical, legal and regulatory review process. The company did not need another place to publish corporate information or research summaries. It needed a format that could make serious science understandable and interesting without oversimplifying it. The goal was to bring audiences closer to the people, questions and persistence behind pharmaceutical innovation. JAR worked with the company to develop an audience-first pharmaceutical podcast built around the human questions inside complex medical research. We used the JAR System to define the job the podcast needed to do, the audience it needed to serve and the result the company wanted to create. That meant resisting the obvious version of the show: scientists talking about company research. Instead, we looked for the bigger question inside each subject. What problem are researchers trying to solve? Why is it difficult? What have scientists learned? What could that mean for patients and medicine? And why should someone outside the company care? From there, JAR developed the editorial strategy, researched topics, sourced and prepared guests, wrote scripts and interview questions, produced the audio and video, created supporting social content and managed distribution. The editorial challenge was simple to describe and difficult to execute: Make pharmaceutical science accessible without making it simplistic. Every episode had to pass two tests. Is the science accurate? Would someone who does not work for the company actually want to hear it? JAR also designed the production workflow around pharma's extensive approval requirements, building medical, legal, regulatory and communications review into the process from the beginning rather than treating compliance as the final hurdle before publication. That gave the team room to make a better show while still meeting the standards required of a global pharmaceutical company.

How a Global Pharmaceutical Company Made Complex Science Worth Listening To

How a Global Pharmaceutical Company Made Complex Science Worth Listening To

Wherever you are in your podcast journey

Contact Us

Contact us

Contact Us